Anzeige
Mehr »
Montag, 27.10.2025 - Börsentäglich über 12.000 News
Automatisierung ist das neue Gold: Telescope Innovations erfindet Entdeckung von Medizin & Materialien neu!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von BioPharma Dive

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
30.09.Trump, Pfizer drug pricing deal short on details, possible impact
30.09.Metsera strengthens case for Pfizer buyout with latest study data
30.09.Crystalys debuts with $205M and plans for a better gout drug
30.09.Star raises another $125M for its blood disease drug
29.09.Emma Walmsley, big pharma's first female CEO, to depart GSK
29.09.Genmab to acquire closely watched cancer drug in $8B Merus buyout
29.09.Moonlake shares crash on mixed study results for immune drug
29.09.Softgel and lipid-based formulations: An opportunity to optimize performance for challenging therapeutics
26.09.Key exemptions could limit impact of Trump's pharmaceutical tariffs
26.09.Crinetics drug to challenge pharma 'Goliaths'; FDA, ARPA move to speed gene therapies
25.09.Lilly's oral SERD gets FDA nod in advanced breast cancer
25.09.Lilly stops trial of muscle-sparing obesity drug
25.09.Capricor readies revised FDA pitch for Duchenne cell therapy
25.09.Cancer patients are living longer than ever. Pain drugmakers haven't kept up.
24.09.UniQure to seek approval of Huntington's gene therapy after trial win
24.09.Acadia to scrap Prader-Willi drug after study setback
24.09.Sanofi Ventures banks $625M to back young biotechs, digital health startups
23.09.Disparity in vaccine access between states roils patients, providers
23.09.Bristol Myers says next-gen blood cancer drug hits goal in key study
23.09.FDA, in unusual step, aims to repurpose old GSK drug as autism treatment
23.09.Scholar Rock SMA drug rejected by FDA over manufacturing concerns
23.09.FDA clears under-the-skin Keytruda; MBX shares double on study data
23.09.Why Xoma, a drug royalty firm, is hunting biotech 'zombies'
22.09.MapLight lines up an IPO in bid to challenge Bristol Myers schizophrenia drug
22.09.Pfizer buys back into obesity drug chase with $4.9B Metsera deal